SCHEMBL7960165

SCHEMBL7960165

Cc1cc(Cl)ccc1C1(O)CCN(CCCc2nnc3n2CCCCC3)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.52
CHRM2 P08172 1/20 0.45
HTR1A P08908 1/20 0.45
ADRA2A P08913 1/20 0.45
ADRA2B P18089 1/20 0.45
ADRA1D P25100 1/20 0.45
HTR2A P28223 1/20 0.45
HTR2C P28335 1/20 0.45
SLC6A4 P31645 1/20 0.45
ADRA1A P35348 1/20 0.45
DRD3 P35462 1/20 0.45
HTR2B P41595 1/20 0.45
HSD11B1 P28845 5/20 0.45
HSD11B2 P80365 2/20 0.45
GAA P10253 2/20 0.44
LMNA P02545 3/20 0.43
HPGD P15428 2/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7963844 0.89 LMNA (0.45) PKMCHRM2HTR1AADRA2AADRA2B
SCHEMBL7959708 0.84 DRD2 (0.55) HTR1AHTR2ASLC6A4ADRA1ADRD3
SCHEMBL7959714 0.83 GAA (0.50) PKMCHRM2HTR1AADRA2AADRA2B
SCHEMBL7957105 0.83 DRD2 (0.46) CHRM2HTR1AADRA2AADRA2BADRA1D
SCHEMBL7959533 0.81 DRD2 (0.48) CHRM2HTR1AADRA2AADRA2BADRA1D
SCHEMBL7961346 0.81 HSD11B1 (0.50) CHRM2HTR1AADRA2AADRA2BADRA1D
SCHEMBL7957371 0.80 LMNA (0.52) HTR1AHTR2AHTR2CSLC6A4DRD3
SCHEMBL7963703 0.79 HSD11B1 (0.41) CHRM2HTR1AADRA2AADRA2BADRA1D
SCHEMBL7964092 0.79 PKM (0.53) PKMCHRM2HTR1AADRA2AADRA2B
SCHEMBL7959210 0.78 DRD2 (0.45) CHRM2HTR1AADRA2AADRA2BADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed